10
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Restoring Wnt/β-catenin signaling is a promising therapeutic strategy for Alzheimer’s disease

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Alzheimer’s disease (AD) is an aging-related neurological disorder characterized by synaptic loss and dementia. Wnt/β-catenin signaling is an essential signal transduction pathway that regulates numerous cellular processes including cell survival. In brain, Wnt/β-catenin signaling is not only crucial for neuronal survival and neurogenesis, but it plays important roles in regulating synaptic plasticity and blood-brain barrier integrity and function. Moreover, activation of Wnt/β-catenin signaling inhibits amyloid-β production and tau protein hyperphosphorylation in the brain. Critically, Wnt/β-catenin signaling is greatly suppressed in AD brain via multiple pathogenic mechanisms. As such, restoring Wnt/β-catenin signaling represents a unique opportunity for the rational design of novel AD therapies.

          Related collections

          Most cited references116

          • Record: found
          • Abstract: found
          • Article: not found

          WNT signaling in bone homeostasis and disease: from human mutations to treatments.

          Low bone mass and strength lead to fragility fractures, for example, in elderly individuals affected by osteoporosis or children with osteogenesis imperfecta. A decade ago, rare human mutations affecting bone negatively (osteoporosis-pseudoglioma syndrome) or positively (high-bone mass phenotype, sclerosteosis and Van Buchem disease) have been identified and found to all reside in components of the canonical WNT signaling machinery. Mouse genetics confirmed the importance of canonical Wnt signaling in the regulation of bone homeostasis, with activation of the pathway leading to increased, and inhibition leading to decreased, bone mass and strength. The importance of WNT signaling for bone has also been highlighted since then in the general population in numerous genome-wide association studies. The pathway is now the target for therapeutic intervention to restore bone strength in millions of patients at risk for fracture. This paper reviews our current understanding of the mechanisms by which WNT signalng regulates bone homeostasis.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The role of brain vasculature in neurodegenerative disorders

            Adequate supply of blood and structural and functional integrity of blood vessels is key to normal brain functioning. On the other hand, cerebral blood flow (CBF) shortfalls and blood-brain barrier (BBB) dysfunction are early findings in neurodegenerative disorders in humans and animal models. Here, we first examine molecular definition of cerebral blood vessels, and pathways regulating CBF and BBB integrity. Then, we examine the role of CBF and BBB in the pathogenesis of Alzheimer’s disease (AD), Parkinson’s disease, Huntington’s disease, amyotrophic lateral sclerosis and multiple sclerosis. We focus on AD as a platform of our analysis because more is known about neurovascular dysfunction in this disease than in other neurodegenerative disorders. Finally, we propose a hypothetical model of AD biomarkers to include brain vasculature as a factor contributing to the disease onset and progression, and suggest a common pathway linking brain vascular contributions to neurodegeneration in multiple neurodegenerative disorders.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Emerging roles of Wnts in the adult nervous system.

              The roles of the Wnt signalling pathway in several developmental processes, including synaptic differentiation, are well characterized. The expression of Wnt ligands and Wnt signalling components in the mature mammalian CNS suggests that this pathway might also play a part in synaptic maintenance and function. In fact, Wnts have a crucial role in synaptic physiology, as they modulate the synaptic vesicle cycle, the trafficking of neurotransmitter receptors and the interaction of these receptors with scaffold proteins in postsynaptic regions. In addition, Wnts participate in adult neurogenesis and protect excitatory synaptic terminals from amyloid-beta oligomer toxicity. Here, the latest insights into the function of Wnt signalling in the adult nervous system and therapeutic opportunities for neurodegenerative diseases such as Alzheimer's and Parkinson's disease are discussed.
                Bookmark

                Author and article information

                Contributors
                Li.Yonghe@mayo.edu
                Journal
                Mol Brain
                Mol Brain
                Molecular Brain
                BioMed Central (London )
                1756-6606
                4 December 2019
                4 December 2019
                2019
                : 12
                : 104
                Affiliations
                [1 ]ISNI 0000 0004 0443 9942, GRID grid.417467.7, Department of Neuroscience, , Mayo Clinic, ; Jacksonville, FL 32224 USA
                [2 ]ISNI 0000 0001 2264 7233, GRID grid.12955.3a, Fujian Provincial Key Laboratory of Neurodegenerative Disease and Aging Research, , Institute of Neuroscience, Medical College, Xiamen University, ; Xiamen, 361102 China
                [3 ]ISNI 0000 0001 0163 8573, GRID grid.479509.6, Neuroscience Initiative, Sanford Burnham Prebys Medical Discovery Institute, ; La Jolla, CA 92037 USA
                Author information
                http://orcid.org/0000-0003-3489-6362
                Article
                525
                10.1186/s13041-019-0525-5
                6894260
                31801553
                318efc56-1c8d-48dd-aa1c-315e79f5b064
                © The Author(s). 2019

                Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

                History
                : 30 October 2019
                : 26 November 2019
                Funding
                Funded by: The Ed and Ethel Moore Alzheimer’s Disease Research Program Pilot Grant from the Florida Department of Health
                Award ID: 9AZ09
                Award Recipient :
                Categories
                Review
                Custom metadata
                © The Author(s) 2019

                Neurosciences
                wnt,alzheimer’s disease,neuronal survival,neurogenesis,synaptic plasticity,drug target
                Neurosciences
                wnt, alzheimer’s disease, neuronal survival, neurogenesis, synaptic plasticity, drug target

                Comments

                Comment on this article